Back to Journals » Drug Design, Development and Therapy » Volume 11

Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models

Total article views   Abstract views HTML views PDF downloads Totals
14,782 Dovepress* 8,726 2,445+ 1,017 11,171
PubMed Central* 0 3,611 287 3,611
Totals 8,726 6,056 1,304 14,782
*Since 11 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 3 4

View citations on PubMed Central and Google Scholar